Effect of pre-enhancement set point on computed tomographic perfusion values in normal liver and metastases to the liver from neuroendocrine tumors

Journal of Computer Assisted Tomography

Volumn 38, Issue 4, 2014, Pages 526-534

  Ng, Chaan S ^a   Chandler, Adam G ^a,b   Yao, James C ^a   Herron, Delise H ^a   Anderson, Ella F ^a   Charnsangavej, Chusilp ^a   Hobbs, Brian P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b GE HEALTHCARE   (United States)

Author keywords

CT perfusion; liver tumor; neuroendocrine metastases; normal liver; perfusion analyses

Indexed keywords

COMPUTERIZED TOMOGRAPHY; HEMODYNAMICS; PATHOLOGY; TUMORS;

BLOOD VOLUMES; COMPUTED TOMOGRAPHIC; CT PERFUSION; LIVER TUMORS; MEAN TRANSIT TIME; NEUROENDOCRINE METASTASIS; NORMAL LIVER; PERFUSION ANALYSIS; REFERENCE STANDARD; SETPOINTS;

BLOOD;

IOVERSOL;

ARTICLE; BLOOD VOLUME; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; HUMAN; LIVER; LIVER METASTASIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; TISSUE BLOOD FLOW; TISSUE PERFUSION;

ADULT; AGED; BLOOD FLOW VELOCITY; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84904746137     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0000000000000053     Document Type: Article

References (33)

1. Miles KA, Charnsangavej C, Lee FT, et al. Application of CT in the investigation of angiogenesis in oncology. Acad Radiol. 2000;7:840-850.
2. Miles KA. Functional computed tomography in oncology. Eur J Cancer. 2002;38:2079-2084.
3. Miles KA, Griffiths MR. Perfusion CT: a worthwhile enhancement? Br J Radiol. 2003;76:220-231.
4. Kambadakone AR, Sahani DV. Body perfusion CT: technique, clinical applications, and advances. Radiol Clin North Am. 2009;47:161-178.
5. Gandhi D, Hoeffner EG, Carlos RC, et al. Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract. Initial results. J Comput Assist Tomogr. 2003;27:687-693.
6. Bisdas S, Baghi M, Wagenblast J, et al. Differentiation of benign and malignant parotid tumors using deconvolution-based perfusion CT imaging: feasibility of the method and initial results. Eur J Radiol. 2007;64:258-265.
7. Makari Y, Yasuda T, Doki Y, et al. Correlation between tumor blood flow assessed by perfusion CT and effect of neoadjuvant therapy in advanced esophageal cancers. J Surg Oncol. 2007;96:220-229.
8. Bellomi M, Petralia G, Sonzogni A, et al. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. Radiology. 2007;244:486-493.
9. Goh V, Halligan S, Hugill JA, et al. Quantitative assessment of colorectal cancer perfusion using MDCT: inter- and intraobserver agreement. Am J Roentgenol. 2005;185:225-231.
10. Goh V, Halligan S, Hugill JA, et al. Quantitative colorectal cancer perfusion measurement using dynamic contrast-enhanced multidetector-row computed tomography: effect of acquisition time and implications for protocols. J Comput Assist Tomogr. 2005;29:59-63.
11. Goh V, Liaw J, Bartram CI, et al. Effect of temporal interval between scan acquisitions on quantitative vascular parameters in colorectal cancer: implications for helical volumetric perfusion CT techniques. Am J Roentgenol. 2008;191:W288-W292.
12. Jensen N, Lock M, Kozak R, et al. SU-GG-I-101: 3D segmentation and rigid registration for minimizing breathing motion effects in liver CT perfusion. Med Phys. 2010;37:3124.
13. Kambadakone AR, Sharma A, Catalano OA, et al. Protocol modifications for CT perfusion (CTp) examinations of abdomen-pelvic tumors: impact on radiation dose and data processing time. Eur Radiol. 2011;21:1293-1300.
14. Sahani DV, Kalva SP, Hamberg LM, et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology. 2005;234:785-792.
15. Ma S-H, Xu K, Xiao Z-W, et al. Peripheral lung cancer: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and cyclin D1 expression. Clin Imaging. 2007;31:165-177.
16. Wang J, Wu N, Cham MD, et al. Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy. Am J Roentgenol. 2009;193:1090-1096.
17. Ng CS, Chandler AG, Wei W, et al. Reproducibility of perfusion parameters obtained from perfusion CT in lung tumors. Am J Roentgenol. 2011;197:113-121.
18. D'Onofrio M, Gallotti A, Mantovani W, et al. Perfusion CT can predict tumoral grading of pancreatic adenocarcinoma. Eur J Radiol. 2013;82:227-233.
19. Klauss M, Stiller W, Pahn G, et al. Dual-energy perfusion-CT of pancreatic adenocarcinoma. Eur J Radiol. 2013;82:208-214.
20. Sahani DV, Holalkere N-S, Mueller PR, et al. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue - initial experience. Radiology. 2007;243:736-743.
21. Zhu AX, Holalkere NS, Muzikansky A, et al. Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma. Oncologist. 2008;13:120-125.
22. Zhang Q, Yuan ZG, Wang DQ, et al. Perfusion CT findings in liver of patients with tumor during chemotherapy. World J Gastroenterol. 2010;16:3202-3205.
23. Kanda T, Yoshikawa T, Ohno Y, et al. CT hepatic perfusion measurement: comparison of three analytic methods. Eur J Radiol. 2012;81:2075-2079.
24. St Lawrence KS, Lee TY. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: II. Experimental validation. J Cereb Blood Flow Metab. 1998;18:1378-1385.
25. Lee TY. Functional CT: physiological models. Trends Biotechnol. 2002;20:S3-S10.
26. Stewart EE, Chen X, Hadway J, et al. Hepatic perfusion in a tumor model using DCE-CT: an accuracy and precision study. Phys Med Biol. 2008;53:4249-4267.
27. Sanelli PC, Lev MH, Eastwood JD, et al. The effect of varying user-selected input parameters on quantitative values in CT perfusion maps. Acad Radiol. 2004;11:1085-1092.
28. Chandler A, Wei W, Herron DH, et al. Semiautomated motion correction of tumors in lung CT-perfusion studies. Acad Radiol. 2011;18:286-293.
29. Chandler A, Wei W, Anderson EF, et al. Validation of motion correction techniques for liver CT perfusion studies. Br J Radiol. 2012;85:e514-e522.
30. Ng CS, Hobbs BP, Chandler AG, et al. Effect of duration of scan acquisition on CT perfusion values in metastases to the liver from neuroendocrine tumors and in normal liver. Radiology. 2013;269:758-67.
31. Soares BP, Dankbaar JW, Bredno J, et al. Automated versus manual post-processing of perfusion-CT data in patients with acute cerebral ischemia: influence on interobserver variability. Neuroradiology. 2009;51:445-451.
32. Yeung TP, Yartsev S, Bauman G, et al. The effect of scan duration on the measurement of perfusion parameters in CT perfusion studies of brain tumors. Acad Radiol. 2013;20:59-65.
33. Goh V, Shastry M, Engledow A, et al. Commercial software upgrades may significantly alter perfusion CT parameter values in colorectal cancer. Eur Radiol. 2011;21:744-749.